Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance
Chell, V, Balmanno, K, Little, A S, Wilson, M, Andrews, S, Blockley, L, Hampson, M, Gavine, P R, Cook, S J
Published in Oncogene (20.06.2013)
Published in Oncogene (20.06.2013)
Get full text
Journal Article
Colorectal cancer cells with the BRAF mutation are addicted to the ERK1 2 pathway for growth factor-independent survival and repression of BIM
Wickenden, J A, Jin, H, Johnson, M, Gillings, A S, Newson, C, Austin, M, Chell, S D, Balmanno, K, Pritchard, C A, Cook, S J
Published in Oncogene (04.12.2008)
Published in Oncogene (04.12.2008)
Get full text
Journal Article
Regulation of cell cycle re-entry by growth, survival and stress signalling pathways
Cook, S J, Balmanno, K, Garner, A, Millar, T, Taverner, C, Todd, D
Published in Biochemical Society transactions (01.02.2000)
Published in Biochemical Society transactions (01.02.2000)
Get more information
Journal Article
Activation of the ERK1/2 Signaling Pathway Promotes Phosphorylation and Proteasome-dependent Degradation of the BH3-only Protein, Bim
Ley, Rebecca, Balmanno, Kathryn, Hadfield, Kathryn, Weston, Claire, Cook, Simon J.
Published in The Journal of biological chemistry (23.05.2003)
Published in The Journal of biological chemistry (23.05.2003)
Get full text
Journal Article
Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion
RAFI, I, TAYLOR, G. A, JOHNSTON, A, CLENDENINN, N, NEWELL, D. R, CALVETE, J. A, BODDY, A. V, BALMANNO, K, BAILEY, N, LIND, M, CALVERT, A. H, WEBBER, S, JACKSON, R. C
Published in Clinical cancer research (01.11.1995)
Get full text
Published in Clinical cancer research (01.11.1995)
Journal Article
Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover
Ley, Rebecca, Ewings, Katherine E, Hadfield, Kathryn, Howes, Elizabeth, Balmanno, Kathryn, Cook, Simon J
Published in The Journal of biological chemistry (05.03.2004)
Published in The Journal of biological chemistry (05.03.2004)
Get full text
Journal Article
Activation of ERK1 2 by ΔRaf-1 : ER represses Bim expression independently of the JNK or PI3K pathways
WESTON, Claire R, BALMANNO, Kathryn, CHALMERS, Claire, HADFIELD, Kathryn, MOLTON, Sarah A, LEY, Rebecca, WAGNER, Erwin F, COOK, Simon J
Published in Oncogene (06.03.2003)
Published in Oncogene (06.03.2003)
Get full text
Journal Article
The relationship between intrinsic thymidylate synthase expression and sensitivity to THYMITAQ in human leukaemia and colorectal carcinoma cell lines
ESTLIN, E. J, BALMANNO, K, CALVERT, A. H, HALL, A. G, LUNEC, J, NEWELL, D. R, PEARSON, A. D. J, TAYLOR, G. A
Published in British journal of cancer (1997)
Published in British journal of cancer (1997)
Get full text
Journal Article
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481)
Millward, M.J., Newell, D.R., Mummaneni, V., Igwemezie, L.N., Balmanno, K., Charlton, C.J., Gumbrell, L., Lind, M.J., Chapman, F., Proctor, M., Simmonds, D., Cantwell, B.M.J., Taylor, G.A., McDaniel, C., Winograd, B., Kaul, S., Barbaiya, R.H., Calvert, A.H.
Published in European journal of cancer (1990) (01.12.1995)
Published in European journal of cancer (1990) (01.12.1995)
Get full text
Journal Article
Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic results
Calvert, A.H., Lind, M.J., Millward, M.M., Cantwell, B.M.J., Gumbrell, L., Proctor, M., Simmons, D., Chapman, F., Robinson, A., Chariton, C., Balmanno, K., Newell, D.
Published in Cancer treatment reviews (1993)
Published in Cancer treatment reviews (1993)
Get full text
Journal Article
Conference Proceeding
ERK1 2 and p38 cooperate to induce a p21 -dependent G cell cycle arrest
Published in Oncogene
(22.04.2004)
Get full text
Journal Article
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group
Newell, D R, Pearson, A D, Balmanno, K, Price, L, Wyllie, R A, Keir, M, Calvert, A H, Lewis, I J, Pinkerton, C R, Stevens, M C
Published in Journal of clinical oncology (01.12.1993)
Published in Journal of clinical oncology (01.12.1993)
Get more information
Journal Article
Phase II trial of trimelamol in refractory ovarian cancer
JUDSON, I. R, CALVERT, A. H, GORE, M. E, BALMANNO, K, GUMBRELL, L. A, PERREN, T, WILTSHAW, E
Published in British journal of cancer (01.02.1991)
Published in British journal of cancer (01.02.1991)
Get full text
Journal Article
Colorectal cancer cells with the [BRAF.sup.V600E] mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM
Wickenden, J.A, Jin, H, Johnson, M, Gillings, A.S, Newson, C, Austin, M, Chell, S.D, Balmanno, K, Pritchard, C.A, Cook, S.J
Published in Oncogene (04.12.2008)
Get full text
Published in Oncogene (04.12.2008)
Journal Article
Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1
Chalmers, Claire J, Balmanno, Kathryn, Hadfield, Kathryn, Ley, Rebecca, Cook, Simon J
Published in Biochemical journal (01.10.2003)
Published in Biochemical journal (01.10.2003)
Get full text
Journal Article
Colorectal cancer cells with the BRAF super(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM
Wickenden, J A, Jin, H, Johnson, M, Gillings, A S, Newson, C, Austin, M, Chell, S D, Balmanno, K, Pritchard, C A, Cook, S J
Published in Oncogene (01.12.2008)
Published in Oncogene (01.12.2008)
Get full text
Journal Article